Brain imaging studies in mood and anxiety disorders: Special emphasis on the amygdala

Annals of the New York Academy of Sciences

Volumn 985, Issue , 2003, Pages 370-388

  Anand, Amit ^a   Shekhar, Anantha ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Brain imaging; Depressionobipolar disorder; FMRI; Mood; MRI; MRS; OCD; Panic disorder; PET; Phobia; PTSD

Indexed keywords

AMYGDALOID NUCLEUS; ANXIETY DISORDER; BIPOLAR DISORDER; BRAIN FUNCTION; BRAIN REGION; CONFERENCE PAPER; DEPRESSION; HUMAN; IMAGING; MOOD DISORDER; NERVE CELL NETWORK; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHOBIA; POSITRON EMISSION TOMOGRAPHY; SYNAPSE; TECHNOLOGY;

EID: 0037274175     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07095.x     Document Type: Conference Paper

References (121)

1. BREMNER, J.D. 2002. Structural changes in the brain in depression and relationship to symptom recurrence. CNS Spectrums 7: 120-139.
2. DAMASIO, A.R. 1997. Neuropsychology: towards a neuropathology of emotion and mood. Nature 386: 769-770.
3. DREVETS, W.C. 2001. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 11: 240-249.
4. KETTER, T.A. 1996. Functional brain imaging, limbic function, and affective disorders. Neuroscientist 2: 55-65.
5. MAYBERG, H. 2000. Depression. In Brain Mapping - The Disorders. J. Mazziotta, A.W. Toga & R. Frackowiak, Eds.: 485-507. Academic Press. London.
6. LYOO, I.K. & P.F. RENSHAW. 2002. Magnetic resonance spectroscopy: current and future applications in psychiatric research. Biol. Psychiatry 51: 195-207.
7. SAXENA, S., A.L. BRODY, J.M. SCHWARTZ & L.R. BAXTER. 1998. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br. J. Psychiatry 35(Suppl): 26-37.
8. SHULMAN, R.G. 2001. Functional imaging studies: linking mind and basic neuroscience. Am. J. Psychiatry 158: 11-20.
9. SOARES, J.C. & J.J. MANN. 1997. The functional neuroanatomy of mood disorders. J. Psychiatric Res. 31: 393-432.
10. STOLE, A.L., P.F. RENSHAW, D.A. YURGELUN-TODD & B.M. COHEN. 2000. Neuroimaging in bipolar disorder: what have we learned? Biol. Psychiatry 48: 505-517. [Erratum appears in Biol. Psychiatry 49: 80 (2001).]
11. YURGELUN-TODD, D.A. & P.F. RENSHAW. 1999. Applications of functional MR imaging to research in psychiatry. Neuroimaging Clin. North Am. 9: 295-308.
12. MAZZIOTTA, J.C. & R.S.J. FRACKOWIAK. 2000. The study of human diseases with brain mapping methods. In Brain Mapping - The Disorders. J. Mazziotta, A.W. Toga & R. Frackowiak, Eds.: 3-31. Academic Press. London.
13. KATO, T., S. TAKAHASHI, T. SHIOIRI & T. INUBUSHI. 1992. Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. J. Affective Disorders 26: 223-230.
14. 1H-magnetic resonance spectroscopy in bipolar disorder. Psychiatry Res. 45: 53-63.
15. 19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder. Am. J. Psychiatry 154:516-522.
16. ARTHURS, O.J. & S. BONIFACE. 2002. How well do we understand the neural origins of the fMRI BOLD signal? Trends Neurosci. 25: 27-31. [Erratum appears in Trends Neurosci. 25: 169 (2002).]
17. LARUELLE, M. 1998. Imaging dopamine transmission in schizophrenia: a review and meta-analysis. Q. J. Nucl. Med. 42: 211-221.
18. ANAND, A., P. VERHOEFF, N. SENECA, et al. 2000. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am. J. Psychiatry 157: 1108-1114.
19. BRADY, L. 2001. Neuroimaging consortium workshop: development of novel PET and SPECT ligands for brain imaging. J. Clin. Pharmacol. Suppl.: 1165-1175.
20. BREMNER, J.D., M. VYTHILINGAM, E. VERMETTEN, et al. 2002. Reduced volume of orbitofrontal cortex in major depression. Biol. Psychiatry 51: 273-279.
21. BREMNER, J.D., M. NARAYAN, E.R. ANDERSON, et al. 2000. Hippocampal volume reduction in major depression. Am. J. Psychiatry 157: 115-118.
22. SOARES, J.C. & J.J. MANN. 1997. The anatomy of mood disorders: review of structural neuroimaging studies. Biol. Psychiatry 41: 86-106.
23. BREMNER, J.D., P. RANDALL, T.M. SCOTT, et al. 1995. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am. J. Psychiatry 152: 973-981.
24. SHELINE, Y.I., P.W. WANG, M.H. GADO, et al. 1996. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA 93: 3908-3913.
25. SHELINE, Y.I., M. SANGHAVI, M.A. MINTUN & M.H. GADO. 1999. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J. Neurosci. 19: 5034-5043.
26. VAKILI, K., S.S. PILLAY, B. LAFER, et al. 2000. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol. Psychiatry 47: 1087-1090.
27. STEFFENS, D.C., C.E. BYRUM, D.R. MCQUOID, et al. 2000. Hippocampal volume in geriatric depression. Biol. Psychiatry 48: 301-309.
28. MERVAALA, E., J. FOHR, M. KONONEN, et al. 2000. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol. Med. 30: 117-125.
29. ASHTARI, M., B.S. GREENWALD, E. KRAMER-GINSBERG, et al. 1999. Hippocampal/amygdala volumes in geriatric depression. Psychol. Med. 29: 629-638.
30. PANTEL, J., J. SCHRODER, M. ESSIG, et al. 1997. Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. J. Affective Disorders 42: 69-83.
31. COFFEY, C.E., W.E. WILKINSON, R.D. WEINER, et al. 1993. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch. Gen. Psychiatry 50: 7-16.
32. KRISHNAN, K.R., W.M. MCDONALD, P.R. ESCALONA, et al. 1992. Magnetic resonance imaging of the caudate nuclei in depression: preliminary observations. Arch. Gen. Psychiatry 49: 553-557.
33. LENZE, E.J. & Y.I. SHELINE. 1999. Absence of striatal volume differences between depressed subjects with no comorbid medical illness and matched comparison subjects. Am. J. Psychiatry 156: 1989-1991.
34. DREVETS, W.C., J.L. PRICE, J.R. SIMPSON, JR., et al. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827.
35. HIRAYASU, Y., M.E. SHENTON, D.F. SALISBURY, et al. 1999. Subgenual cingulate cortex volume in first-episode psychosis. Am. J. Psychiatry 156: 1091-1093.
36. DUMAN, R.S. 2002. Synaptic plasticity and mood disorders. Mol. Psychiatry 7: S29-S34.
37. ANAND, A. & D.S. CHARNEY. 2000. Norepinephrine dysfunction in depression. J. Clin. Psychiatry 61: 16-24.
38. KETTER, T.A., P.J. ANDREASON, M.S. GEORGE, et al. 1996. Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. Arch. Gen. Psychiatry 53: 59-69.
39. MAYBERG, H.S., M. LIOTTI, S.K. BRANNAN, et al. 1999. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156: 675-682.
40. DREVETS, W.C., J.L. PRICE, M.E. BARDGETT, et al. 2002. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol. Biochem. Behavior 71: 431-447.
41. SHELINE, Y.I., D.M. BARCH, J.M. DONNELLY, et al. 2001. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiatry 50: 651-658.
42. ABERCROMBIE, H.C., S.M. SCHAEFER, C.L. LARSON, et al. 1998. Metabolic rate in the right amygdala predicts negative affect in depressed patients. NeuroReport 9: 3301-3307.
43. Ho, A.P., J.C. GILLIN, M.S. BUCHSBAUM, et al. 1996. Brain glucose metabolism during non-rapid eye movement sleep in major depression: a positron emission tomography study. Arch. Gen. Psychiatry 53: 645-652.
44. NOFZINGER, E.A., T.E. NICHOLS, C.C. MELTZER, et al. 1999. Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F]FDG PET studies. Psychiatry Res. 91: 59-78.
45. SIEGLE, G.J., S.R. STEINHAUER, M.E. THASE, et al. 2002. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol. Psychiatry 51: 693-707.
46. KIMBRELL, T.A., T.A. KETTER, M.S. GEORGE, et al. 2002. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol. Psychiatry 51: 237-252.
47. THOMAS, K.M., W.C. DREVETS, R.E. DAHL, et al. 2001. Amygdala response to fearful faces in anxious and depressed children. Arch. Gen. Psychiatry 58: 1057-1063.
48. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol. Psychiatry 44: 1090-1098.
49. DREVETS, W.C., E. FRANK, J.C. PRICE, et al. 1999. PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry 46: 1375-1387.
50. YATHAM, L.N., P.F. LIDDLE, I.S. SHIAH, et al. 2000. Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch. Gen. Psychiatry 57: 850-858.
51. 18F]setoperone during depressive illness and antidepressant treatment with clomipramine. Biol. Psychiatry 45: 180-186.
52. PARSEY, R.V., M.A. OQUENDO, Y. ZEA-PONCE, et al. 2001. Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biol. Psychiatry 50: 313-322.
53. LAASONEN-BALK, T., J. KUIKKA, H. VIINAMAKI, et al. 1999. Striatal dopamine transporter density in major depression. Psychopharmacology 144: 282-285.
54. SANACORA, G., G.F. MASON, D.L. ROTHMAN, et al. 1999. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 56: 1043-1047.
55. 13C-MRS. Paper presented at a meeting of the American College of Neuropsychopharmacology. Puerto Rico.
56. MOORE, C.M., J.D. CHRISTENSEN, B. LAFER, et al. 1997. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. Am. J. Psychiatry 154: 116-118.
57. RENSHAW, P.F., A.M. PAROW, F. HIRASHIMA, et al. 2001. Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression. Am. J. Psychiatry 158: 2048-2055.
58. CHARLES, H.C., F. LAZEYRAS, K.R. KRISHNAN, et al. 1994. Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 18: 1121-1127.
59. ENDE, G., D.F. BRAUS, S. WALTER, et al. 2000. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch. Gen. Psychiatry 57: 937-943.
60. 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 248: 289-295.
61. 1H-magnetic resonance spectroscopy at 1.5 tesla. J. Psychiatric Res. 32: 411-420.
62. ALTSHULER, L.L., G. BARTZOKIS, T. GRIEDER, et al. 1998. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. Arch. Gen. Psychiatry 55: 663-664.
63. STRAKOWSKI, S.M., M.P. DELBELLO, K.W. SAX, et al. 1999. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch. Gen. Psychiatry 56: 254-260.
64. TEBARTZ VAN ELST, L., F.G. WOERMANN, L. LEMIEUX & M.R. TRIMBLE. 1999. Amygdala enlargement in dysthymia: a volumetric study of patients with temporal lobe epilepsy. Biol. Psychiatry 46: 1614-1623.
65. FRODL, T., E. MEISENZAHL, T. ZETZSCHE, et al. 2002. Enlargement of the amygdala in patients with a first episode of major depression. Biol. Psychiatry 51: 708-714.
66. ALTSHULER, L.L., A. CONRAD, P. HAUSER, et al. 1991. Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging. Arch. Gen. Psychiatry 48: 482-483.
67. SHELINE, Y.I., M.H. GADO & J.L. PRICE. 1998. Amygdala core nuclei volumes are decreased in recurrent major depression. NeuroReport 9: 2023-2028.
68. SWAYZE, V.W., 2ND, N.C. ANDREASEN, R.J. ALLIGER, et al. 1992. Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study. Biol. Psychiatry 31: 221-240.
69. CHAKOS, M.H., J.A. LIEBERMAN, R.M. BILDER, et al. 1994. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am. J. Psychiatry 151: 1430-1436.
70. MOORE, G.J., J.M. BEBCHUK, I.B. WILDS, et al. 2000. Lithium-induced increase in human brain grey matter. Lancet 356: 1241-1242.
71. ALTSHULER, L.L., J.G. CURRAN, P. HAUSER, et al. 1995. T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. Am. J. Psychiatry 152: 1139-1144.
72. VIDEBECH, P. 1997. MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiatrica Scand. 96: 157-168.
73. BAXTER, L.R., JR., J.M. SCHWARTZ, M.E. PHELPS, et al. 1989. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch. Gen. Psychiatry 46: 243-250.
74. 18F-labelled fluorodeoxyglucose and positron emission tomography. Br. J. Psychiatry 169: 509-516.
75. 18F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium. Am. J. Psychiatry 159: 768-774.
76. PEARLSON, G.D. 1999. Structural and functional brain changes in bipolar disorder: a selective review. Schizophrenia Res. 39: 133-140. [Discussion: 162.]
77. WINSBERG, M.E., N. SACHS, D.L. TATE, et al. 2000. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol. Psychiatry 47: 475-481.
78. OHARA, K., H. ISODA, Y. SUZUKI, et al. 1999. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder. Psychiatry Res. 92: 83-91.
79. MOORE, G.J., J.M. BEBCHUK, K. HASANAT, et al. 2000. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol. Psychiatry 48: 1-8.
80. DAVANZO, P., M.A. THOMAS, K. YUE, et al. 2001. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 24: 359-369.
81. 7Li magnetic resonance studies at 3 T. Biol. Psychiatry 49: 437-443.
82. SACHS, G.S., P.F. RENSHAW, B. LAFER, et al. 1995. Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study. Biol. Psychiatry 38: 422-428.
83. DE BELLIS, M.D., J. HALL, A.M. BORING, et al. 2001. A pilot longitudinal study of hippocampal volumes in pediatric maltreatment-related posttraumatic stress disorder. Biol. Psychiatry 50: 305-309.
84. CARRION, V.G., C.F. WEEMS, S. ELIEZ, et al. 2001. Attenuation of frontal asymmetry in pediatric posttraumatic stress disorder. Biol. Psychiatry 50: 943-951.
85. BREMNER, J.D., P. RANDALL, E. VERMETTEN, et al. 1997. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse: a preliminary report. Biol. Psychiatry 41: 23-32.
86. GURVITS, T.V., M.E. SHENTON, H. HOKAMA, et al. 1996. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol. Psychiatry 40: 1091-1099.
87. DRIESSEN, M., J. HERRMANN, K. STAHL, et al. 2000. Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Arch. Gen. Psychiatry 57: 1115-1122.
88. BONNE, O., D. BRANDES, A. GILBOA, et al. 2001. Longitudinal MRI study of hippocampal volume in trauma survivors with PTSD. Am. J. Psychiatry 158: 1248-1251.
89. BREMNER, J.D. 1999. Does stress damage the brain? Biol. Psychiatry 45: 797-805.
90. FRODL, T., E.M. MEISENZAHL, T. ZETZSCHE, et al. 2002. Hippocampal changes in patients with a first episode of major depression. Am. J. Psychiatry 159: 1112-1118.
91. SAXENA, S., A.L. BRODY, K.M. MAIDMENT, et al. 1999. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 21: 683-693.
92. RAUCH, S.L., D.D. DOUGHERTY, G.R. COSGROVE, et al. 2001. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol. Psychiatry 50: 659-667.
93. BRODY, A.L., S. SAXENA, J.M. SCHWARTZ, et al. 1998. FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res. 84: 1-6.
94. SAXENA, S., A.L. BRODY, M.L. Ho, et al. 2001. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol. Psychiatry 50: 159-170.
95. BREITER, H.C., N.L. ETCOFF, P.J. WHALEN, et al. 1996. Response and habituation of the human amygdala during visual processing of facial expression. Neuron 17: 875-887.
96. BREITER, H.C. & S.L. RAUCH. 1996. Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala. Neuroimage 4: S127-S138.
97. BIRBAUMER, N., W. GRODD, O. DIEDRICH, et al. 1998. fMRI reveals amygdala activation to human faces in social phobics. NeuroReport 9: 1223-1226.
98. LABAR, K.S., J.C. GATENBY, J.C. GORE, et al. 1998. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 20: 937-945.
99. WHALEN, P.J., S.L. RAUCH, N.L. ETCOFF, et al. 1998. Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J. Neurosci. 18: 411-418.
100. RAUCH, S.L., P.J. WHALEN, L.M. SHIN, et al. 2000. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol. Psychiatry 47: 769-776.
101. JAVANMARD, M., J. SHLIK, S.H. KENNEDY, et al. 1999. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol. Psychiatry 45: 872-882.
102. SIMPSON, J.R., JR., W.C. DREVETS, A.Z. SNYDER, et al. 2001. Emotion-induced changes in human medial prefrontal cortex. II. During anticipatory anxiety. Proc. Natl. Acad. Sci. USA 98: 688-693.
103. MALIZIA, A.L., V.J. CUNNINGHAM, C.J. BELL, et al. 1998. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch. Gen. Psychiatry 55: 715-720.
104. TIIHONEN, J., J. KUIKKA, P. RASANEN, et al. 1997. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis. Mol. Psychiatry 2: 463-471.
105. 123I]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol. Psychiatry 47: 96-106.
106. SCHNEIER, F.R., M.R. LIEBOWITZ, A. ABI-DARGHAM, et al. 2000. Low dopamine D(2) receptor binding potential in social phobia. Am. J. Psychiatry 157: 457-459.
107. TIIHONEN, J., J. KUIKKA, K. BERGSTROM, et al. 1997. Dopamine reuptake site densities in patients with social phobia. Am. J. Psychiatry 154: 239-242.
108. IH-magnetic resonance spectroscopy. Arch. Gen. Psychiatry 58: 556-561.
109. DAGER, S.R., K.I. MARRO, T.L. RICHARDS & G.D. METZGER. 1994. Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic. Am. J. Psychiatry 151: 57-63.
110. DAGER, S.R., W.L. STRAUSS, K.I. MARRO, et al. 1995. Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am. J. Psychiatry 152: 666-672.
111. ROSENBERG, D.R., F.P. MACMASTER, M.S. KESHAVAN, et al. 2000. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J. Am. Acad. Child Adolesc. Psychiatry 39: 1096-1103.
112. MOORE, G.J., F.P. MACMASTER, C. STEWART & D.R. ROSENBERG. 1998. Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder. J. Am. Acad. Child Adolesc. Psychiatry 37: 663-667.
113. FREEMAN, T.W., D. CARDWELL, C.N. KARSON & R.A. KOMOROSKI. 1998. In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. Magn. Resonance Med. 40: 66-71.
114. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res. 74: 173-176.
115. FITZGERALD, K.D., G.J. MOORE, L.A. PAULSON, et al. 2000. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biol. Psychiatry 47: 174-182.
116. HYMAN, S.E. 1998. Brain neurocircuitry of anxiety and fear: implications for clinical research and practice. Biol. Psychiatry 44: 1201-1203.
117. SILVERMAN, D.H., S.S. GAMBHIR, H.W. HUANG, et al. 2002. Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. J. Nucl. Med. 43: 253-266.
118. ERNST, M. & J.M. RUMSEY. 2000. Functional neuroimaging in child psychiatry. Curr. Psychiatry Rep. 2: 124-130.
119. RAPOPORT, J.L., F.X. CASTELLANOS, N. GOGATE, et al. 2001. Imaging normal and abnormal brain development: new perspectives for child psychiatry. Austr. N. Zeal. J. Psychiatry 35: 272-281.
120. MARIA MORESCO, R., C. MESSA, G. LUCIGNANI, et al. 2001. PET in psychopharmacology. Pharmacol. Res. 44: 151-159.
121. MARTINEZ, D., A. BROFT & M. LARUELLE. 2001. Imaging neurochemical endophenotypes: promises and pitfalls. Pharmacogenomics 2: 223-237.